Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
LAMA and ICS in moderate asthma - Respirology - Interviews - McMaster Textbook of Internal Medicine
Principal differences between inhaler devices used to deliver LAMA/LABA... | Download Scientific Diagram
Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
xmlinkhub
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane? | American Board of Family Medicine
Prognostic and functional impact of perioperative LAMA/LABA inhaled therapy in patients with lung cancer and chronic obstructive pulmonary disease | BMC Pulmonary Medicine | Full Text
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Navigating New Treatment Options for COPD | Consultant360
Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease - ScienceDirect
Inhaled corticosteroid use and the incidence of lung cancer in COPD | European Respiratory Society
Lung deposition measured by FRI of inhaled LAMA via standard jet nebulizer or DPI - Fluidda : Fluidda
Sinusitis | Free Full-Text | The Role of Dual Bronchodilation and the Conscientious Use of Inhaled Corticosteroid in COPD
Rinsing of oropharynx and storage place of respiratory medicine inhaler: A cross‐sectional audit - Okauchi - 2019 - Journal of General and Family Medicine - Wiley Online Library
Incruse Ellipta: new once-daily LAMA inhaler for COPD
Comparison of annual changes of PFT conduction rate (a), inhaled LAMA... | Download Scientific Diagram
inhaled drugs for asthma and COPD | Download Table
Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit–harm modelling study - ScienceDirect
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d | COPD
![PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7a56c4ea6ccc14edcd10985bf0259da67b0b0376/13-Figure1-1.png "PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar")
PDF] Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). | Semantic Scholar
Rational use of inhaled corticosteroids for the treatment of COPD | npj Primary Care Respiratory Medicine
Henna KD on X: "Inhaled steroids have been linked to increased pneumonia esp. n the elderly. We are moving towards LAMA+LABA combination inhalers for COPD. https://t.co/rJsiKkPnUU" / X
COPD in 2017 Hard enough before Now, new drugs and New phenotypes!
